Litcius/Paper detail

Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma

Lindsay Young, Parissa Tabrizian, Jeffrey Sung, D. Biederman, V. Bishay, M. Ranade, Rahul Patel, F. Nowakowski, A. Fischman, R. Lookstein, Edward Kim

2022Journal of Vascular and Interventional Radiology17 citationsDOI

Topics & Concepts

MedicineHepatocellular carcinomaAscitesInternal medicineGastroenterologyStage (stratigraphy)Liver cancerConcomitantProportional hazards modelSurvival analysisPerformance statusCancerPaleontologyBiologyHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesOrgan Transplantation Techniques and Outcomes
Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma | Litcius